BofA analyst Joanna Gajuk downgraded UnitedHealth (UNH) to Neutral from Buy with a price target of $350, down from $560.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- “Time to Buy the Dip” Analysts Remain Bullish on UnitedHealth Stock (UNH) despite Sell-Off
- UnitedHealth downgraded to Market Perform from Strong Buy at Raymond James
- ‘This is a Major Fumble,’ Says Top Investor About UnitedHealth Stock
- UnitedHealth’s Strategic Growth Focus and Financial Resilience Underpin Buy Rating
- Truist says near-term visibility remains challenging for UnitedHealth